NCT01437267View on ClinicalTrials.gov

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Children, Older Infants and Infants

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Typhoid Fever
Interventions
BIOLOGICAL

Vi-CRM197 vaccine

BIOLOGICAL

Pneumococcal conjugate vaccine

BIOLOGICAL

Vi Polysaccharide (PS) vaccine

Trial Locations (1)

1781

Research Institute for Tropical Medicine (RITM), Alabang, Muntinlupa City

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY